郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Rationally targeted, conformationally constrained, oxetane-modified oligonucleotides demonstrate efficient gene-silencing activity in a cellular system.

期刊：Annals of the New York Academy of Sciences发表年份：2005作者：J B Opalinska; A M Gewirtz
阅读更多 →

药效评价Preparation and characterization of calibration beads for sorting cells expressing a beta-lactamase gene reporter.

期刊：Cytometry. Part A : the journal of the International Society for Analytical Cytology发表年份：2005作者：Michael E Cunningham; Marianna Kapitskaya; Konstantin Petrukhin; Bohumil Bednar
阅读更多 →

药效评价Discovery of 2-aminothiazole-4-carboxamides, a novel class of muscarinic M(3) selective antagonists, through solution-phase parallel synthesis.

期刊：Chemical & pharmaceutical bulletin发表年份：2005作者：Yufu Sagara; Morihiro Mitsuya; Minaho Uchiyama; Yoshio Ogino; Toshifumi Kimura; Norikazu Ohtake; Toshiaki Mase
阅读更多 →

药效评价Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist.

期刊：Journal of medicinal chemistry发表年份：2005作者：Simon E Ward; Frank P Harrington; Laurie J Gordon; Susanna C Hopley; Claire M Scott; Jeannette M Watson
阅读更多 →